Hu Liu

Biography

Hu Liu, Ph.D., School of Pharmacy, Memorial University of Newfoundland, ST. John's, NL, CANADA Following his B.Sc. (Pharmacy) in 1982 from Beijing Medical College and M.Sc. (Pharmaceutical chemistry) degrees from Beijing Medical University (now Peking University) in Beijing, China, Dr. Liu obtained his Ph.D. degree in lipid and lipoprotein biochemistry from the University of Alberta in 1993 in Canada. He then did his post-doctoral training in pharmacology and medicinal chemistry at the University of Michigan, Ann Arbor MI, USA. In 1994, Dr. Liu joined School of Pharmacy, Memorial University, and he is a full professor. From 1999 to 2004, Dr. Liu was a recipient of the Career Award in Health Sciences sponsored by Medical Research Council of Canada (MRC) which was renamed as Canadian Institutes of Health Research (CIHR) and the Health Sciences Foundation of Canada's Research Based Pharmaceutical Companies (Rx&D-HRF). In 2000, he was awarded with the AstraZeneca New Investigator Research Award by the Association of Faculties of Pharmacy of Canada (AFPC). He served as an internal grants reviewer for the Pharmaceutical Sciences Committee of CIHR. In 2002, together with three colleagues Dr. Liu founded the former North Atlantic  Hu Liu, Ph.D., School of Pharmacy, Memorial University of Newfoundland, ST. John's, NL, CANADA Following his B.Sc. (Pharmacy) in 1982 from Beijing Medical College and M.Sc. (Pharmaceutical chemistry) degrees from Beijing Medical University (now Peking University) in Beijing, China, Dr. Liu obtained his Ph.D. degree in lipid and lipoprotein biochemistry from the University of Alberta in 1993 in Canada. He then did his post-doctoral training in pharmacology and medicinal chemistry at the University of Michigan, Ann Arbor MI, USA. In 1994, Dr. Liu joined School of Pharmacy, Memorial University, and he is a full professor. From 1999 to 2004, Dr. Liu was a recipient of the Career Award in Health Sciences sponsored by Medical Research Council of Canada (MRC) which was renamed as Canadian Institutes of Health Research (CIHR) and the Health Sciences Foundation of Canada's Research Based Pharmaceutical Companies (Rx&D-HRF). In 2000, he was awarded with the AstraZeneca New Investigator Research Award by the Association of Faculties of Pharmacy of Canada (AFPC). He served as an internal grants reviewer for the Pharmaceutical Sciences Committee of CIHR. In 2002, together with three colleagues Dr. Liu founded the former North Atlantic 

Research Interest

Pharmacy, Health Sciences